Shp2 suppresses the adipogenic differentiation of preadipocyte 3T3-L1 cells at an early stage.
Ontology highlight
ABSTRACT: Tyrosine phosphatase protein Shp2 is a potential therapeutic target for obesity. However, the mechanism of Shp2 during adipogenesis is not fully understood. The present study investigated the role of Shp2 in the terminal differentiation of preadipocytes. The results showed that Shp2 suppressed adipocyte differentiation in 3T3-L1 cells; overexpression of Shp2 reduced lipid droplet production in 3T3-L1 cells, whereas Shp2 knockdown increased lipid droplet production in 3T3-L1 cells. Furthermore, inhibition of Shp2 activity also enhanced adipocyte differentiation. Interestingly, Shp2 expression was specifically decreased early during differentiation in response to stimulation with the dexamethasone-methylisobutylxanthine-insulin (DMI) hormone cocktail. During the first 2 days of differentiati
SUBMITTER: Tao J
PROVIDER: S-EPMC4979423 | biostudies-literature | 2016
REPOSITORIES: biostudies-literature
ACCESS DATA